title: The large sample bounds on the principal strata effect with application to a prostate cancer prevention trial.
abstract: Issues of post-randomization selection bias and truncation-by-death can arise in randomized clinical trials; for example, in a cancer prevention trial, an outcome such as cancer severity is undefined for individuals who do not develop cancer. Restricting analysis to a subpopulation selected after randomization can give rise to biased outcome comparisons. One approach to deal with such issues is to consider the principal strata effect (PSE, or equally, the survivor average causal effect). PSE is defined as the effect of treatment on the outcome among the subpopulation that would have been selected under either treatment arm. Unfortunately, the PSE cannot generally be estimated without the identifying assumptions; however, the bounds can be derived using a deterministic causal model. In this paper, we propose a number of assumptions for deriving the bounds with narrow width. The assumptions and bounds, which differ from those introduced by Zhang and Rubin (2003), are illustrated using data from a randomized prostate cancer prevention trial.
authors.affiliation: Kinki University School of Medicine, Japan.
authors.forename: Yasutaka
authors.initials: Y
authors.lastname: Chiba
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000494:pharmacology; D000368:Aged; D015982:Bias; D056808:Biostatistics / Q000379:methods; D018120:Finasteride / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D015337:Multicenter Studies as Topic / Q000706:statistics & numerical data; D015995:Prevalence; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data*
chemical_list: D058891:5-alpha Reductase Inhibitors; D018120:Finasteride